Insights
US Election: Impacts on Biosimilars and Generics
With Donald Trump returning to the presidency, significant policy changes may lie ahead, particularly affecting the healthcare sector. The Trump
Leadership Skills Shaping the Future of Pharma
As we approach the second half of 2024, the pharmaceutical industry finds itself in the midst of a transformative journey,
Leadership Styles For Pharmaceutical Executives
The pharmaceutical industry is a demanding and challenging environment for executive leaders, pressured by regulatory shifts, digital transformation, global supply
CEO Onboarding – A Comprehensive Guide
The appointment of a new CEO is a critical moment in the life of any organisation. Whether it’s a startup
Generics and the Importance of Marketing
Generic medicines have been proven to be just as safe and effective as their branded counterparts, but despite this, they
5 key strategies for hiring a CEO
Hiring a CEO is probably the most business-critical decision you’ll ever make. It puts tremendous pressure on your board of
- All Posts
- Biosimilars
- Executive Search
- Generics
- Hiring
- HR
- Leadership
- Wellbeing
There is no denying that a lot of change is happening in the world of employment, something that hasn’t been seen for many years. Key vacancies are unfilled, employee retention...
There are a lot of changes happening in the world of business, and this is all down to the way that leaders are building their organisations. With world pandemics, supply...
Introduction “Biosimilar” medicines are characteristically different from generic medicines because of their molecular size and structure, together with the sheer complexity and cost of their development. For example, a 500mg...
This week is national stress awareness week and we have seen a lot of articles on how to help ease and remove stress for employees within a business but very...
Branded products are certainly good for the brand owner’s bottom line–but are they good for the consumer? Current received wisdom says no. As Naomi Klein argued in No Logo, greater access to...
There are a lot of major advancements linked to biological medicines, including many pathological conditions such as autoimmune diseases and cancer. Biosimilars, a lower cost alternative to many biological medicines,...
The COVID-19 pandemic had a huge impact on the pharmaceutical industry; it disrupted supply chains, delayed production and led to a shortage of medicines. In fact, it’s estimated that close...
If you think there’s too much red tape in your industry, spare a thought for pharma. Pharma manufacturers are subject to 76,000 restrictions–and with patients’ lives on the line, they...
Back in 2020, the worldwide pharmaceutical market had a value of $1.27 trillion; $387.92 billion and $28.235 billion of this was made up of the generics market and biosimilars market...